Coniglio Weighs In On Cannabis Trends For 2025
In our latest Trade To Black podcast for Wednesday, December 18, 2024, Anthony Coniglio, CEO of NewLake Capital (OTCQB: NLCP), joins hosts Shadd Dales and Anthony Varrell to take a look ahead at the cannabis trends we might be able to expect in 2025. The post-election period market has been rough on the industry, and many of the leaders in the industry are currently experiencing 52-week lows. But there’s a few silver linings.
Currently, stocks like Trulieve (OTC: TCNNF), Curaleaf (OTC: CURLF), and Verano Holdings (OTC: VRNOF) have been among the leaders hard-hit since Donald Trump won the election. Even though Trump endorsed Amendment 3 in Florida, rec use legislation failed to meet the 60% approval threshold. Governor Ron DeSantis played a huge role in that failure, and since then, marijuana stocks have fallen 50% or more in the last six weeks.
We’ll examine Organigram’s earning report, which has some include $159.8 million in net revenue, 17.6% growth in recreational sales, and a 37% adjusted gross margin. Despite this, the cannabis stock fell 8%, which Anthony Varrell feels is part of broader market trends.
In positive trends at the state level, over the past 48 hours, both South Carolina and Wisconsin announced a cannabis framework for 2025, and Ohio’s adult-use cannabis will fully kick in Q1. Governor Youngkin continues to veto legislation in Virginia, but South Carolina and Kentucky are also advancing medical marijuana programs, and Pennsylvania seems to be actively pursuing the idea of adult-use.
Vireo Health announced a $75 million equity financing deal to expand its footprint to seven states, nine cultivation facilities, and 48 dispensaries, including notable assets like “The Flowery” in Florida. Vireo acquired a significant footprint in Missouri, including 11 dispensaries primarily in St. Louis and Kansas City.
We’ll discuss all these trends and what they mean for cannabis investors heading into 2025.